Episode 18: Karen Petrou and David Brint - BioBonds

Episode 18 March 23, 2022 00:55:46
Episode 18: Karen Petrou and David Brint - BioBonds
Few & Far Between: Conversations from the Front Lines of Drug Development
Episode 18: Karen Petrou and David Brint - BioBonds

Mar 23 2022 | 00:55:46

/

Show Notes

On this week’s Few & Far Between podcast episode, Biorasi’s CEO, Chris O'Brien, welcomes Karen Petrou and David Brint for an in-depth discussion on BioBonds and how they can jumpstart funding in clinical research for rare disease and other disorders.

Other Episodes

Episode 55

July 09, 2025 00:38:46
Episode Cover

Episode 55: Julio G. Martinez-Clark, CEO and Co-Founder at bioaccess®

How much do you know about clinical trials in Latin America? Take a deep dive with us as we explore the benefits and risks...

Listen

Episode 3

June 09, 2021 00:39:48
Episode Cover

Episode 3: Danielle Drayton, PhD, CEO of REACH Market Research

On today’s podcast, host Wayne Bowden, Vice President of Partnerships and Strategy at Biorasi, will be discussing insights into market research solutions for rare...

Listen

Episode 45

December 12, 2024 00:37:26
Episode Cover

Episode 46: Dr. Carsten Rudolph, CEO and Managing Director at Ethris

"It's really a very important challenge we had from the very beginning, to see how to stabilize nanoparticles with the messenger RNA so they...

Listen